Associations of perfluoroalkyl substances with metabolic-associated fatty liver disease and non-alcoholic fatty liver disease: NHANES 2017–2018
Cancer Causes & Control · 2024
DOI: 10.1007/s10552-024-01865-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Causes & Control, 2024. Verfasst von Yuxiao Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Wannan Medical College, 22 Wenchang West Road, Wuhu, 241000, Anhui, China. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Fluorocarbons, Nutrition Surveys. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: Anhui Province University Collaborative Innovation Project, Anhui Provincial Quality Engineering for Colleges and Universities, Quality Engineering Project of Wannan Medical College.
Abstract (Originalsprache)
OBJECTIVES: This study investigated the potential effects of perfluoroalkyl substance (PFAS) in serum on MAFLD, NAFLD, and liver fibrosis. METHODS: Our sample included 696 participants (≥ 18 years) from the 2017-2018 NHANES study with available serum PFASs, covariates, and outcomes. Using the first quartile of PFAS as the reference group, we used weighted binary logistic regression and multiple ordered logistic regression used to analyze the relationship between PFAS and MAFLD, NAFLD, and liver fibrosis and multiple ordinal logistic regression to investigate the relationship between PFAS and MAFLD, NAFLD, and liver fibrosis and calculated the odds ratio (OR) and 95% confidence interval for each chemical. Finally, stratified analysis and sensitivity analysis were performed according to gender, age, BMI, and serum cotinine concentration. RESULTS: A total of 696 study subjects were included, including 212 NAFLD patients (weighted 27.03%) and 253 MAFLD patients (weighted 32.65%). The quartile 2 of serum PFOA was positively correlated with MAFLD and NAFLD (MAFLD, OR 2.29, 95% CI 1.05-4.98; NAFLD, OR 2.37, 95% CI 1.03-5.47). PFAS were not significantly associated with liver fibrosis after adjusting for potential confounders in MAFLD and NAFLD. Stratified analysis showed that PFOA was strongly associated with MAFLD, NAFLD, and liver fibrosis in males and obese subjects. In women over 60 years old, PFHxS was also correlated with MAFLD, NAFLD, and liver fibrosis. CONCLUSION: The serum PFOA was positively associated with MAFLD and NAFLD in US adults. After stratified analysis, the serum PFHxS was correlated with MFALD, NAFLD, and liver fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Public Health, Wannan Medical College, 22 Wenchang West Road, Wuhu, 241000, Anhui, China.
- Department of Otolaryngology Head and Neck Surgery, The First Affiliated Hospital of Wannan Medical College, Wuhu, 241001, Anhui, China.
- School of Public Health, Wannan Medical College, 22 Wenchang West Road, Wuhu, 241000, Anhui, China. huangyewindow@163.com.
- School of Public Health, Wannan Medical College, 22 Wenchang West Road, Wuhu, 241000, Anhui, China. 20100030@wnmc.edu.cn.
Förderung
- Anhui Province University Collaborative Innovation Project
- Anhui Provincial Quality Engineering for Colleges and Universities
- Quality Engineering Project of Wannan Medical College
- Key Projects of Anhui Provincial Department of Education
- Key scientific research project of Wannan Medical College
Zitieren
APA
Zhang, Y., Zhang, M., Jiang, S., Hu, H., Wang, X., Yu, F., Huang, Y., & Liang, Y. (2024). Associations of perfluoroalkyl substances with metabolic-associated fatty liver disease and non-alcoholic fatty liver disease: NHANES 2017–2018. Cancer Causes & Control. https://doi.org/10.1007/s10552-024-01865-5
Vancouver
Zhang Y, Zhang M, Jiang S, Hu H, Wang X, Yu F, et al. Associations of perfluoroalkyl substances with metabolic-associated fatty liver disease and non-alcoholic fatty liver disease: NHANES 2017–2018. Cancer Causes & Control. 2024. doi:10.1007/s10552-024-01865-5
BibTeX
@article{Zhang2024,
author = {Zhang, Yuxiao and Zhang, Min and Jiang, Shanjiamei and Hu, Heng and Wang, Xinzhi and Yu, Fan and Huang, Yue'e and Liang, Yali},
title = {Associations of perfluoroalkyl substances with metabolic-associated fatty liver disease and non-alcoholic fatty liver disease: NHANES 2017–2018},
journal = {Cancer Causes & Control},
year = {2024},
doi = {10.1007/s10552-024-01865-5}
}
EUVIMED